Ricerca Announces Business Development Agreement with LSP
The collaboration and settlement grants LSP the ability to market the full spectrum of services offered by Ricerca to those companies represented by LSP, increasing the Japanese, Korean and overall Asian markets for Ricerca.
“We also believe our collaboration will largely help our customers develop new compounds and products for tomorrow and will provide higher value to meet customerneeds,” stated LSP Executive Director, Hiroko Suzuki.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025